Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2006-06-06

European Medicines Agency adopts a positive opinion for the use of Prozac in the treatment of children and adolescents suffering from depression

View source ↗

Summary

EMA adopts a positive opinion for using Prozac (fluoxetine) to treat depression in children and adolescents, indicating potential authorization for this age gro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prozac (Fluoxetine)